{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:08:14Z","timestamp":1762160894716},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,3,6]],"date-time":"2011-03-06T00:00:00Z","timestamp":1299369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12072-011-9262-2","type":"journal-article","created":{"date-parts":[[2011,3,6]],"date-time":"2011-03-06T18:44:42Z","timestamp":1299437082000},"page":"906-912","source":"Crossref","is-referenced-by-count":9,"title":["Serum retinol binding protein 4 and clinical outcome in postoperative biliary atresia"],"prefix":"10.1007","volume":"5","author":[{"given":"Maneerat","family":"Chayanupatkul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sittisak","family":"Honsawek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Voranush","family":"Chongsrisawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Vimolket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,6]]},"reference":[{"key":"9262_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0140-6736(99)03492-3","volume":"355","author":"PJ Mckirnan","year":"2000","unstructured":"Mckirnan PJ, Baker AJ, Kelly DA. The frequency and outcome of biliary atresia in the UK and Ireland. Lancet 2000;355:25\u201329","journal-title":"Lancet"},{"key":"9262_CR2","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/hep.510230652","volume":"23","author":"WF Balistreri","year":"1996","unstructured":"Balistreri WF, Grand R, Hoofnagle JH, Suchy FJ, Ryckman FC, Perlmutter DH, et al. Biliary atresia: current concepts and research directions. Summary of symphosium. Hepatology 1996;23:1682\u20131692","journal-title":"Hepatology"},{"key":"9262_CR3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00000658-199709000-00014","volume":"226","author":"RP Altman","year":"1997","unstructured":"Altman RP, Lilly JR, Greenfield J, Weinburg A, van Leeuwen K, Flanigan L. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg 1997;226:348\u2013353","journal-title":"Ann Surg"},{"key":"9262_CR4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00042737-200304000-00020","volume":"5","author":"HH A-Kader","year":"2003","unstructured":"A-Kader HH, Abdel-Hameed A, Al-Shabrawi M, Mohsen N, El-Karaksy H, Hassanein B, et al. Is biliary atresia an autoimmune disease? Eur J Gastroenterol Hepatol 2003;5:447","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9262_CR5","doi-asserted-by":"crossref","first-page":"87R","DOI":"10.1203\/01.PDR.0000159569.57354.47","volume":"57","author":"CL Mark","year":"2005","unstructured":"Mark CL, Sokol RJ. Unraveling the pathogenesis and etiology of biliary atresia. Pediatr Res 2005;57:87R\u201394R","journal-title":"Pediatr Res"},{"key":"9262_CR6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1478-3231.2008.01826.x","volume":"28","author":"OA Gressner","year":"2008","unstructured":"Gressner OA, Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 2008;28:1065\u20131079","journal-title":"Liver Int"},{"key":"9262_CR7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006;10:76\u201399","journal-title":"J Cell Mol Med"},{"key":"9262_CR8","first-page":"855","volume":"27","author":"JH Chuang","year":"2004","unstructured":"Chuang JH, Wang PW, Tai MH. An adipocentric view of liver fibrosis and cirrhosis. Chang Gung Med J 2004;27:855\u2013868","journal-title":"Chang Gung Med J"},{"key":"9262_CR9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/edrv-10-3-308","volume":"10","author":"WS Blaner","year":"1989","unstructured":"Blaner WS. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev 1989;10:308\u2013316","journal-title":"Endocr Rev"},{"key":"9262_CR10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","volume":"436","author":"Q Yang","year":"2005","unstructured":"Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356\u2013362","journal-title":"Nature"},{"key":"9262_CR11","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","volume":"354","author":"TE Graham","year":"2006","unstructured":"Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552\u20132563","journal-title":"N Engl J Med"},{"key":"9262_CR12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hep.22316","volume":"48","author":"S Petta","year":"2008","unstructured":"Petta S, Camma C, Di Marco V, Alessi N, Barbaria F, Cabibi D, et al. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. Hepatology 2008;48:28\u201337","journal-title":"Hepatology"},{"key":"9262_CR13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2265.2007.03072.x","volume":"68","author":"JA Seo","year":"2008","unstructured":"Seo JA, Kim NH, Park SY, Kim HY, Ryu OH, Lee KW, et al. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol 2008;68:555\u2013560","journal-title":"Clin Endocrinol"},{"key":"9262_CR14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2265.2008.03295.x","volume":"70","author":"MJ Bahr","year":"2009","unstructured":"Bahr MJ, Boeker KHW, Manns MP, Tietge UJF. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis. Clin Endocrinol 2009;70:60\u201365","journal-title":"Clin Endocrinol"},{"key":"9262_CR15","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2337\/dc06-2323","volume":"30","author":"E Yagmur","year":"2007","unstructured":"Yagmur E, Weiskirchen R, Gressner AM, Trautwein C, Tacke F. Insulin resistance in liver cirrhosis is not associated with the circulating retinol-binding protein 4. Diabetes Care 2007;30:1168\u20131172","journal-title":"Diabetes Care"},{"key":"9262_CR16","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1872-034X.2009.00534.x","volume":"39","author":"M Schina","year":"2009","unstructured":"Schina M, Koskinas J, Tiniakos D, Hadziyannis E, Savvas S, Karamanos B, et al. Circulating and liver tissue levels of retinol-binding protein 4 in non-alcoholic fatty liver disease. Hepatol Res 2009;39:972\u2013978","journal-title":"Hepatol Res"},{"key":"9262_CR17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cgh.2008.12.031","volume":"7","author":"V Nobili","year":"2009","unstructured":"Nobili V, Alkhouri N, Alisi A, Ottino S, Lopez R, Manco M, et al. Retinol-binding protein 4: promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7:575\u2013579","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9262_CR18","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/MCG.0b013e3181a0998d","volume":"43","author":"N Alkhouri","year":"2009","unstructured":"Alkhouri N, Lopez R, Berk M, Feldstein AE. Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease. J Clin Gastroenterol 2009;43:985\u2013989","journal-title":"J Clin Gastroenterol"},{"key":"9262_CR19","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/hep.22544","volume":"48","author":"F Tacke","year":"2008","unstructured":"Tacke F, Weiskirchen R, Trautwein C. Liver function critically determines serum retinol-binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis. Hepatology 2008;48:1724\u20131725","journal-title":"Hepatology"},{"key":"9262_CR20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2008.10.023","volume":"50","author":"JF Huang","year":"2009","unstructured":"Huang JF, Dai CY, Yu ML, Shin SJ, Hsieh MY, Huang CF, et al. Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C. J Hepatol 2009;50:471\u2013478","journal-title":"J Hepatol"},{"key":"9262_CR21","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.3748\/wjg.v16.i43.5467","volume":"16","author":"S Honsawek","year":"2010","unstructured":"Honsawek S, Chayanupatkul M, Chongsrisawat V, Vejchapipat P, Poovorawan Y. Increased osteopontin and liver stiffness measurement by transient elastography in biliary atresia. World J Gastroenterol 2010;16:5467\u2013547","journal-title":"World J Gastroenterol"},{"key":"9262_CR22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1651-2227.2007.00596.x","volume":"97","author":"S Honsawek","year":"2008","unstructured":"Honsawek S, Chaiwatanarat T, Chongsrisawat V, Thawornsuk N, Vejchapipat P, Poovorawan Y. Circulating leptin levels and bone mineral density in children with biliary atresia. Acta Paediatr 2008;97:206\u2013211","journal-title":"Acta Paediatr"},{"key":"9262_CR23","first-page":"1184","volume":"55","author":"S Honsawek","year":"2008","unstructured":"Honsawek S, Chongsrisawat V, Vejchapipat P, Thawornsuk N, Poovorawan Y. High levels of serum basic fibroblast growth factor in children with biliary atresia. Hepatogastroenterology 2008;55:1184\u20131188","journal-title":"Hepatogastroenterology"},{"key":"9262_CR24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518\u2013526","journal-title":"Hepatology"},{"key":"9262_CR25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MPG.0b013e31819de7ba","volume":"49","author":"HK Chang","year":"2009","unstructured":"Chang HK, Park YJ, Koh H, Kim SM, Chung KS, Oh JT, et al. Hepatic fibrosis scan for liver stiffness score measurement: a useful preendoscopic screening test for the detection of varices in postoperative patients with biliary atresia. J Pediatr Gastroenterol Nutr 2009;49:323\u2013328","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9262_CR26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","volume":"128","author":"L Castara","year":"2005","unstructured":"Castara L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver fibrosis for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343\u2013350","journal-title":"Gastroenterology"},{"key":"9262_CR27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.22426","volume":"48","author":"M Bluher","year":"2008","unstructured":"Bluher M, Tonjes A, Stumvoll M. Dose retinol-binding protein 4 cause or reflect fatty liver disease? Hepatology 2008;48:4\u20136","journal-title":"Hepatology"},{"key":"9262_CR28","doi-asserted-by":"crossref","first-page":"G589","DOI":"10.1152\/ajpcell.1997.272.6.C1980","volume":"272","author":"M Ohata","year":"1997","unstructured":"Ohata M, Lin M, Satre M, Tsukamoto H. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol 1997;272:G589\u2013G596","journal-title":"Am J Physiol"},{"key":"9262_CR29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/abbi.2000.1723","volume":"376","author":"L Wang","year":"2000","unstructured":"Wang L, Attard FA, Tankersley LR, Potter JJ, Mezey E. Effect of retinoic acid on the enhancing effect of acetaldehyde on mouse type I collagen expression. Arch Biochem Biophys 2000;376:191\u2013198","journal-title":"Arch Biochem Biophys"},{"key":"9262_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-511X-7-29","volume":"7","author":"SK Frey","year":"2008","unstructured":"Frey SK, Nagl B, Henze A, Raila J, Schlosser B, Berg T, et al. Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver. Lipids Health Dis 2008;7:29","journal-title":"Lipids Health Dis"},{"key":"9262_CR31","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1093\/emboj\/18.17.4633","volume":"18","author":"L Quadro","year":"1999","unstructured":"Quadro L, Blaner WS, Salchow DJ, Vogel S, Piantedosi R, Gouras P, et al. Impaired retinol function and vitamin A availability in mice lacking retinol-binding protein. EMBO J 1999;18:4444\u20134633","journal-title":"EMBO J"},{"key":"9262_CR32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.2005.069153","volume":"55","author":"J Foucher","year":"2006","unstructured":"Foucher J, Chanteloup E, Vergniol J. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55:403\u2013408","journal-title":"Gut"},{"key":"9262_CR33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/MEG.0b013e32833283cb","volume":"22","author":"C Cengiz","year":"2010","unstructured":"Cengiz C, Ardicoglu Y, Bulut S, Boyacioglu S. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: dose it have a significant impact on pathogenesis. Eur J Gastroenterol Hepatol 2010;22:813\u2013819","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-011-9262-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-011-9262-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-011-9262-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T23:20:50Z","timestamp":1560036050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-011-9262-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,6]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9262"],"URL":"https:\/\/doi.org\/10.1007\/s12072-011-9262-2","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,6]]}}}